End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
124 MXN | -2.36% |
|
-.--% | -2.36% |
Sales 2024 * | 39.35M 726M 3.1B | Sales 2025 * | 58.17M 1.07B 4.59B | Capitalization | 80.48M 1.48B 6.35B |
---|---|---|---|---|---|
Net income 2024 * | -119M -2.2B -9.38B | Net income 2025 * | -78M -1.44B -6.15B | EV / Sales 2024 * | -1.19 x |
Net cash position 2024 * | 127M 2.35B 10.05B | Net cash position 2025 * | 54.53M 1.01B 4.3B | EV / Sales 2025 * | 0.45 x |
P/E ratio 2024 * |
-0.74
x | P/E ratio 2025 * |
-1.41
x | Employees | 166 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.02% |
Latest transcript on Marinus Pharmaceuticals, Inc.
1 day | -2.36% | ||
3 months | -2.36% | ||
6 months | -2.36% | ||
Current year | -2.36% |
![Extreme 124](/images/extremecours_fleche.png)
![Extreme 124](/images/extremecours_fleche.png)
![Extreme 83](/images/extremecours_fleche.png)
![Extreme 80](/images/extremecours_fleche.png)
![Extreme 80](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Scott Braunstein
CEO | Chief Executive Officer | 60 | 04/09/18 |
Steven Pfanstiel
DFI | Director of Finance/CFO | 51 | 11/04/21 |
Joseph Hulihan
CTO | Chief Tech/Sci/R&D Officer | 68 | 05/11/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tim Mayleben
BRD | Director/Board Member | 63 | 30/11/08 |
Scott Braunstein
CEO | Chief Executive Officer | 60 | 04/09/18 |
Elan Ezickson
BRD | Director/Board Member | 60 | 11/12/19 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+50.70% | 791B | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B |
- Stock Market
- Equities
- MRNS Stock
- MRNS * Stock